IFNA1 and systemic lupus erythematosus: Systemic lupus erythematosus (SLE) describes a heterogeneous set of clinical phenotypes associated with type I interferon (IFN) signaling upregulation and the presence of autoantibodies targeting nuclear autoantigens [1].